Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)

Research output: Contribution to journalArticle

Abstract

The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable heterogeneity exists within this definitional umbrella. CRE may mechanistically differ by whether they do or do not produce carbapenemases. Moreover, patients can acquire CRE through multiple pathways: endogenously through antibiotic selective pressure on intestinal microbiota, exogenously through horizontal transmission or through a combination of these factors. Some evidence suggests that non-carbapenemase-producing CRE may be more frequently acquired by antibiotic exposure and carbapenemase-producing CRE via horizontal transmission, but definitive data are lacking. This review examines types of CRE resistance mechanisms, antibiotic exposure and horizontal transmission pathways of CRE acquisition, and the implications of these heterogeneities to the development of evidence-based CRE healthcare epidemiology policies. In our Expert Commentary & Five-Year View, we outline specific nosocomial CRE knowledge gaps and potential methodological approaches for their resolution.

Original languageEnglish (US)
Pages (from-to)95-108
Number of pages14
JournalExpert Review of Anti-Infective Therapy
Volume14
Issue number1
DOIs
StatePublished - Jan 2 2016

Fingerprint

Carbapenems
Enterobacteriaceae
Infection Control
Anti-Bacterial Agents
Centers for Disease Control and Prevention (U.S.)
Microbial Drug Resistance
Epidemiology
Delivery of Health Care

Keywords

  • Antibiotic stewardship (AS)
  • Antimicrobial drug resistance
  • Carbapenem-resistant Enterobacteriaceae (CRE)
  • Carbapenemase
  • Carbapenemase-producing Enterobacteriaceae (CPE)
  • Hospital epidemiology
  • Transmission

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology
  • Virology

Cite this

@article{19fd59b56a2a4a308960572919f34856,
title = "Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)",
abstract = "The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable heterogeneity exists within this definitional umbrella. CRE may mechanistically differ by whether they do or do not produce carbapenemases. Moreover, patients can acquire CRE through multiple pathways: endogenously through antibiotic selective pressure on intestinal microbiota, exogenously through horizontal transmission or through a combination of these factors. Some evidence suggests that non-carbapenemase-producing CRE may be more frequently acquired by antibiotic exposure and carbapenemase-producing CRE via horizontal transmission, but definitive data are lacking. This review examines types of CRE resistance mechanisms, antibiotic exposure and horizontal transmission pathways of CRE acquisition, and the implications of these heterogeneities to the development of evidence-based CRE healthcare epidemiology policies. In our Expert Commentary & Five-Year View, we outline specific nosocomial CRE knowledge gaps and potential methodological approaches for their resolution.",
keywords = "Antibiotic stewardship (AS), Antimicrobial drug resistance, Carbapenem-resistant Enterobacteriaceae (CRE), Carbapenemase, Carbapenemase-producing Enterobacteriaceae (CPE), Hospital epidemiology, Transmission",
author = "Goodman, {K. E.} and Patricia Simner and Pranita Tamma and Aaron Milstone",
year = "2016",
month = "1",
day = "2",
doi = "10.1586/14787210.2016.1106940",
language = "English (US)",
volume = "14",
pages = "95--108",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)

AU - Goodman, K. E.

AU - Simner, Patricia

AU - Tamma, Pranita

AU - Milstone, Aaron

PY - 2016/1/2

Y1 - 2016/1/2

N2 - The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable heterogeneity exists within this definitional umbrella. CRE may mechanistically differ by whether they do or do not produce carbapenemases. Moreover, patients can acquire CRE through multiple pathways: endogenously through antibiotic selective pressure on intestinal microbiota, exogenously through horizontal transmission or through a combination of these factors. Some evidence suggests that non-carbapenemase-producing CRE may be more frequently acquired by antibiotic exposure and carbapenemase-producing CRE via horizontal transmission, but definitive data are lacking. This review examines types of CRE resistance mechanisms, antibiotic exposure and horizontal transmission pathways of CRE acquisition, and the implications of these heterogeneities to the development of evidence-based CRE healthcare epidemiology policies. In our Expert Commentary & Five-Year View, we outline specific nosocomial CRE knowledge gaps and potential methodological approaches for their resolution.

AB - The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable heterogeneity exists within this definitional umbrella. CRE may mechanistically differ by whether they do or do not produce carbapenemases. Moreover, patients can acquire CRE through multiple pathways: endogenously through antibiotic selective pressure on intestinal microbiota, exogenously through horizontal transmission or through a combination of these factors. Some evidence suggests that non-carbapenemase-producing CRE may be more frequently acquired by antibiotic exposure and carbapenemase-producing CRE via horizontal transmission, but definitive data are lacking. This review examines types of CRE resistance mechanisms, antibiotic exposure and horizontal transmission pathways of CRE acquisition, and the implications of these heterogeneities to the development of evidence-based CRE healthcare epidemiology policies. In our Expert Commentary & Five-Year View, we outline specific nosocomial CRE knowledge gaps and potential methodological approaches for their resolution.

KW - Antibiotic stewardship (AS)

KW - Antimicrobial drug resistance

KW - Carbapenem-resistant Enterobacteriaceae (CRE)

KW - Carbapenemase

KW - Carbapenemase-producing Enterobacteriaceae (CPE)

KW - Hospital epidemiology

KW - Transmission

UR - http://www.scopus.com/inward/record.url?scp=84954395700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954395700&partnerID=8YFLogxK

U2 - 10.1586/14787210.2016.1106940

DO - 10.1586/14787210.2016.1106940

M3 - Article

C2 - 26535959

AN - SCOPUS:84954395700

VL - 14

SP - 95

EP - 108

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 1

ER -